Skip to main content

Table 5 Comparison of the number of detected genes in the 38 samples shared between all platforms

From: Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitization

Gene symbol nCounter® BioMark HD™ OpenArray®
ABCB4 1 (3%) 31 (82%) 18 (47%)
FDXR D 37 (97%) 36 (95%)
OR5B21 0 (0%) D 37 (97%)
ADAM20 11 (29%) D 35 (92%)
HIST1H3J 36 (95%) D 36 (95%)
GDF11 30 (79%) D D
LY96 D D 36 (95%)
TLR6 36 (95%) D D
CD86 33 (87%) D 36 (95%)
FASN D D 37 (97%)
PFAS D D 36 (95%)
MAPK13 37 (97%) D D
GDAP2 D D 36 (95%)
TMEM97 35 (92%) D D
DHX33 35 (92%) D D
RFC2 D D 37 (97%)
ACLY D D 35 (92%)
TXNRD1 D D 37 (97%)
HPRT1 D D 37 (97%)
GAPDH D D 37 (97%)
  1. The set of 33 transcripts were measured in the 38 chemical stimulations shared between all platforms. The table illustrates the number of detected calls for a specific transcript across the 38 samples with percentage in parentheses. Table lists only transcripts declared as undetected in any of the stimulations on either nCounter®, BioMark HD™ or OpenArray®. D denotes that transcript is present in all samples.